ImmunoScape is a biotechnology company focused on transforming cancer therapy with our novel Seed-and-Boost approach.
Joined May 2018
- Tweets 190
- Following 70
- Followers 437
- Likes 90
105 Photos and videos
Mar 7
We are proud to announce the execution of a MOU with a premier NCI-designated U.S. Comprehensive Cancer Center to fast-track our pipeline program. We are also super thrilled to welcome Leonardo DiCaprio as a strategic investor.
businesswire.com/news/home/2…
3
14
916
Mar 7
ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies is thrilled and pleased to announced an exclusive in-licensing deal with Cue Biopharma.
immunoscape.com/singapore-ba…
623
Mar 7
We are excited to announce a strategic collaboration and exclusive licensing agreement with Cue Biopharma to advance a novel in vivo T-cell expansion Seed-and-Boost approach for solid tumor therapy.
cuebiopharma.gcs-web.com/nod…
1
651
3 Mar 2024
ImmunoScape CEO Choon-Peng Ng will make two appearances on March 5 at BioCentury-BayHelix East-West Summit: Singapore, presenting on ImmunoScape in the morning and participating in an afternoon panel on how Asia will drive biotech’s golden age. Learn more: conferences.biocentury.com/e…
1
4
2,309
1 Mar 2024
On Wednesday, March 6 at 2:55 p.m. EST, ImmunoScape VP of Innovation Michael Fehlings, PhD, will participate in a panel discussion “AI for Therapeutics: Upstream Applications; Downstream Challenges.” Register here: webinars.liebertpub.com/e/th…
1
6
1,376
4 Jan 2024
2023 was an exciting year at ImmunoScape, featuring transformative technical progress, new partnerships, expert additions to our leadership team and more. Read our 2023 Recap for a look back at the highlights, plus a preview of what’s on the way for 2024: immunoscape-5454518.hs-sites…
4
638
21 Dec 2023
With EDDC, we aim to develop off-the-shelf TCR-based molecules to make these therapeutics more accessible to a much broader patient population at lower production costs and shorter timelines for the patients.
#machinelearning #therapeutics #immunotherapy
businesswire.com/news/home/2…
3
410
20 Dec 2023
We are excited to work with the team at MiNK Therapeutics to fast track the development of next generation TCR-based therapies for solid tumors.
#machinelearning #therapeutics #immunotherapy
Learn more: globenewswire.com/news-relea…
2
309
19 Dec 2023
ImmunoScape is using data-driven approaches to foster the discovery of novel and efficacious TCRs across a variety of tumor indications. Read how our diverse TCR portfolio generates opportunities beyond T cell engineering. #machinelearning #immunotherapy insideprecisionmedicine.com/…
3
4
240
19 Dec 2023
If you're interested in meeting the ImmunoScape team at JP Morgan & to learn more about our progress on the development of novel TCR-based therapeutics using our Deep Immunomics platform, send us a message at info@immunoscape.com
#jpm2024 #immunotherapy #tcells #machinelearning
176
7 Feb 2023
Ayesha Siddiqui from @AsiaBioSpectrum spoke with our CEO and Co-Founder Choon-Peng (Choon) Ng about the progress around cancer research in Asia for her recent piece. See what Choon had to say in the full piece: bit.ly/3x27bh6
#cancerresearch #apac #immunology
216
18 Jan 2023
Our CEO and co-founder Choon-Peng Ng recently spoke with @AsiaBioSpectrum about how our Deep Immunomics & machine learning platforms can discover novel TCR-based therapeutics against a diverse range of tumor antigens: bit.ly/3Hbt3fV #immunology #tcells
1
197
4 Jan 2023
We are excited to attend the 41st Annual JPM Health Care Conference in San Francisco next week! Our CEO & VP of Discovery will be on-site January 9-10th.
If you're interested in setting up a meeting email us at info@immunoscape.com or send us a DM. #Immunology #JPM23
845
15 Dec 2022
Are you attending the 41st Annual JPM Healthcare Conference in San Francisco next month? Our CEO & VP of Discovery will be on-site 1/9-1/10. If you're interested in setting up a meeting, DM us or email info@immunoscape.com. #JPM23 #Immunology
244
10 Nov 2022
One of our senior scientists in discovery, Juliana Barclay, will be presenting at @sitcancer SITC 2022 in Boston this Friday, November 11: sitcancer.org/2022/home #immunology #tcells #SITC22
1
8 Nov 2022
As ImmunoScape grows, we are hiring a Research Associate, Discovery in San Diego. For more information, please visit our careers page: bit.ly/3UneKsd
#wearegrowing #wearehiringnow #hiringtoday #joinourteam #hiring #biomedicaljobs #researchjobs #researchassociate
ALT We're Hiring - Research Associate - Discovery
2
7 Nov 2022
As ImmunoScape grows, we are hiring a Research Scientist, Technology Development in San Diego. For more information, please visit our careers page: bit.ly/3heRZsw
#wearehiringnow #hiringtoday #joinourteam #hiring #biomedicaljobs #researchjobs #researchscientist
1
4 Nov 2022
As ImmunoScape grows, we are hiring a Director, Discovery in San Diego. For more information, please visit our careers page: bit.ly/3DEcAhc
#wearegrowing #wearehiringnow #hiringtoday #joinourteam #hiring #biomedicaljobs #researchjobs #director
ALT We're Hiring - Director - Discovery
1
20 Oct 2022
One of our senior scientists in discovery, Juliana Barclay, will be presenting at @sitcancer 2022 in Boston on November 11. She will present on the discovery and development of t-cell receptors for adoptive t-cell therapy against solid tumors. sitcancer.org/2022/home #SITC22
2
6
ImmunoScape retweeted
21 Sep 2022
@ImmunoScape's Dan MacLeod in the Discovery track this morning: Discovery of TCRs Targeting Novel Antigens Using Deep Immunomics
#CARTCR #immunotherapy
1
2